Iqvia reports fourth-quarter and full-year 2022 results; issues full-year 2023 guidance

Research triangle park, n.c.--(business wire)--iqvia holdings inc. (“iqvia”) (nyse:iqv), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended december 31, 2022. fourth-quarter 2022 operating results revenue for the fourth quarter of $3,739 million increased 2.8 percent on a reported basis and 7.
IQV Ratings Summary
IQV Quant Ranking